Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=55217On October 6, 2004, Arrowhead Research Corporation hosted a conference call. The transcript of the conference call is attached below: ARROWHEAD RESEARCH CORPORATION Moderator: Bruce Stewart October 6, 2004 ...http://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=5521738013210Paul Lee Arrowhead and Shire Enter into Collaboration and License Agreement to Develop Peptide-Targeted Therapeutics PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation ( ARWR), a targeted therapeutics company, today announced that it has signed a research collaboration and license agreement w...http://www.siliconinvestor.com/readmsg.aspx?msgid=2861168112/18/2012 7:17:41 AMPaul LeeArrowhead Presents Data Showing 99% Target Knockdown in Monkeys Without Toxicity Using Subcutaneous Formulation of Dynamic Polyconjugate siRNA Delivery System PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation ( ARWR), a targeted therapeutics company, announced that David Lewis, Ph.D., Vice Presiden...http://www.siliconinvestor.com/readmsg.aspx?msgid=2850667910/29/2012 7:32:16 AMPaul Lee Arrowhead Announces Dosing of First Patient with Anti-Obesity Treatment Adipotide® in a Phase 1 Clinical Trial PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ:ARWR), a targeted therapeutics company, today announced that the first patient has been dosed in a Phase 1 clinical t...http://www.siliconinvestor.com/readmsg.aspx?msgid=282590517/11/2012 9:56:30 AMlindalibAnd the silence is deafening. ARWR continues to get funding and makes progress, yet no reaction?http://www.siliconinvestor.com/readmsg.aspx?msgid=281903886/6/2012 9:56:05 AMPaul LeeArrowhead Research advances ARC-520 into IND-enabling studies for the treatment of hepatitis B and provides guidance on development timeline (ARWR) 3.70 : Co announced that its hepatitis B virus program has completed all internal preclinical requirements and has named a clinical candidate. As such, the Company has init...http://www.siliconinvestor.com/readmsg.aspx?msgid=281901916/6/2012 8:20:00 AMPaul Lee Arrowhead Research Corporation Acquires Alvos Therapeutics and Proprietary Library of Targeting Peptides Pioneer in targeting for tumors and tumor vasculature in humans PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ: ARWR - News), a nanomedicine company with development...http://www.siliconinvestor.com/readmsg.aspx?msgid=280739734/11/2012 7:54:33 AMPaul Lee ArrowHead Research issued patent covering siRNA Inhibitors of HIF-2a Arrowhead Research announced that the United States Patent and Trademark Office has issued U.S. Patent titled “Compositions and use of EPAS1 inhibitors.” Included in the patent are claims directed to siRNA sequences targeting the hypoxia-...http://www.siliconinvestor.com/readmsg.aspx?msgid=279793552/29/2012 7:54:38 AMPaul Lee Alnylam and Arrowhead Form Collaboration and Licensing Agreement – Arrowhead Receives License from Alnylam to Develop RNAi TherapeuticToward Hepatitis B Virus (HBV) – – Alnylam Gains Access to Arrowhead’s Dynamic Polyconjugate (DPC) Delivery Technology for “Alnylam 5x15” Target – CAMBRIDGE, Mass. & PASAD...http://www.siliconinvestor.com/readmsg.aspx?msgid=278618751/5/2012 8:15:17 AMmikehunt2 Arrowhead Announces FDA Clearance to Initiate AdipotideTM Phase I Clinical Trial PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ: ARWR - News), a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application...http://www.siliconinvestor.com/readmsg.aspx?msgid=278593321/4/2012 8:10:59 AMmikehunt2 NISSHA PRINTING : Announcement of Joint Development Agreement with Unidym, Inc. on carbon nanotube-based products Nissha Printing Co., Ltd. (hereinafter, Nissha), the world's leading manufacturer of touch panels and Unidym, Inc. (hereinafter, Unidym), a wholly owned subsidiary of Wisepower Co., Ltd. (KOSDAQ: 0406...http://www.siliconinvestor.com/readmsg.aspx?msgid=2780704012/6/2011 9:15:06 AMGlenn PetersenArrowhead has completed its one-for-ten reverse split: Arrowhead Implements Reverse Stock Split By Deborah Crowe Los Angeles Business Journal Wednesday, November 16, 2011 Pasadena nanotech company Arrowhead Research Corp. late Wednesday said it carried out a 1-for-10 reverse stock split of common stock that had ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2778000411/21/2011 8:33:49 PMmikehunt2 Arrowhead Research Subsidiary Ablaris Therapeutics Data Published in Science Translational Medicine Demonstrates Weight Loss in Obese Monkeys Last update: 11/10/2011 7:00:02 AM PASADENA, Calif., Nov 10, 2011 (BUSINESS WIRE) -- Arrowhead Research Corporation (ARWR), a nanomedicine company with development programs i...http://www.siliconinvestor.com/readmsg.aspx?msgid=2775849611/10/2011 8:22:58 AMmikehunt2Arrowhead Research Publishes White Paper on RNAi Delivery Technology Acquired from Roche - A Well-Designed and Powerful Solution to the siRNA Delivery PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ: ARWR - News), a nanomedicine company with development programs in oncology, obesity, ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2775095211/7/2011 7:25:48 AMmikehunt2 Vascular Research Further Validates the Drug Development Programs of Arrowhead Research Subsidiary Ablaris Therapeutics and Alvos Ablaris Therapeutics, Inc., a subsidiary of Arrowhead, and Alvos Therapeutics, Inc., was published in the Proceedings of the National Academy of Sciences (“PNAS”), one of the world’s ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2774233911/2/2011 4:14:07 PMmikehunt2 Arrowhead Research Corporation Acquires Roche RNA Assets and Site Three New Delivery Technologies, Broad RNAi IP, and Advanced Operations to Drive Clinical Development, Partnerships, and Revenue Roche Takes Equity Stake in Arrowhead and Rights to Negotiate Future RNAi Candidates Conference Call Scheduled for To...http://www.siliconinvestor.com/readmsg.aspx?msgid=2772174710/24/2011 6:25:49 AM